import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-reconstitution-protocol-step-by-step-ovn19",
  title: "How to Reconstitute Peptides: Step-by-Step Research Protocol (2026)",
  description:
    "Complete research protocol for reconstituting lyophilized peptides — choosing the right diluent, calculating concentrations, aseptic technique, and post-reconstitution storage.",
  category: "Research Protocols",
  readMinutes: 8,
  publishedAt: "2026-06-22",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Lyophilized peptides — freeze-dried to a stable powder — require reconstitution before use in research applications. Proper reconstitution directly affects peptide stability, accurate dosing, and the integrity of experimental results. This guide outlines the standard protocol used in pre-clinical research settings.",
    },
    {
      type: "heading",
      text: "Why Reconstitution Protocol Matters",
    },
    {
      type: "paragraph",
      text: "Peptides in lyophilized form are stable at controlled temperatures for extended periods. Once reconstituted in aqueous solution, they become significantly more vulnerable to hydrolysis (water-mediated peptide bond cleavage), aggregation (formation of non-bioactive molecular clusters), and bacterial contamination in multi-use vials. Getting reconstitution right means choosing the correct diluent, calculating concentration accurately, and following aseptic technique throughout.",
    },
    {
      type: "heading",
      text: "Choosing the Right Diluent",
    },
    {
      type: "subheading",
      text: "Bacteriostatic Water (BW)",
    },
    {
      type: "paragraph",
      text: "Bacteriostatic water — sterile water containing 0.9% benzyl alcohol — is the most commonly used diluent for research peptides. The benzyl alcohol acts as a preservative, inhibiting bacterial growth in multi-use vials. Recommended for GHRH analogs and GHS peptides (CJC-1295, Ipamorelin, Sermorelin, Hexarelin), BPC-157, TB-500, PT-141, and any peptide that will be drawn from a single vial over multiple sessions.",
    },
    {
      type: "subheading",
      text: "Sterile Water for Injection",
    },
    {
      type: "paragraph",
      text: "Plain sterile water (no preservative) is appropriate when the entire vial will be used in a single application, or when the peptide is incompatible with benzyl alcohol. Single-use reconstitution with sterile water minimizes preservative exposure in sensitive applications.",
    },
    {
      type: "subheading",
      text: "0.6% Acetic Acid Solution",
    },
    {
      type: "paragraph",
      text: "Some hydrophobic sequences or peptides with poor aqueous solubility require an acidic diluent for initial dissolution. IGF-1 and some GH-releasing peptide variants dissolve more completely in dilute acetic acid. Protocol: dissolve initially in acetic acid, then dilute to final target concentration with bacteriostatic water or phosphate-buffered saline (PBS).",
    },
    {
      type: "heading",
      text: "Equipment Required",
    },
    {
      type: "list",
      items: [
        "Lyophilized peptide vial",
        "Diluent (bacteriostatic water or appropriate alternative)",
        "Insulin syringe (1 mL, 28–31 gauge) or appropriate research-grade syringe",
        "Alcohol swabs (70% isopropyl)",
        "Clean preparation surface",
        "Calculator for concentration math",
      ],
    },
    {
      type: "heading",
      text: "Step-by-Step Reconstitution Protocol",
    },
    {
      type: "subheading",
      text: "Step 1: Prepare Your Environment",
    },
    {
      type: "paragraph",
      text: "Work in a clean environment. Wipe down the preparation surface with 70% isopropyl alcohol. Wash hands thoroughly or use nitrile gloves. This step is non-negotiable for maintaining aseptic conditions.",
    },
    {
      type: "subheading",
      text: "Step 2: Calculate Your Target Concentration",
    },
    {
      type: "paragraph",
      text: "Determine the concentration needed before adding any liquid. The formula: Concentration (mcg/mL) = Peptide mass (mcg) ÷ Volume of diluent (mL). For example: a 5 mg (5,000 mcg) vial reconstituted with 2.5 mL of diluent yields 2 mg/mL (2,000 mcg/mL). The same vial with 5 mL yields 1 mg/mL.",
    },
    {
      type: "subheading",
      text: "Step 3: Swab and Pierce",
    },
    {
      type: "paragraph",
      text: "Wipe both the peptide vial septum and the diluent vial septum with a fresh alcohol swab. Allow to air-dry for 10–15 seconds before piercing. This reduces surface contamination risk.",
    },
    {
      type: "subheading",
      text: "Step 4: Draw Diluent",
    },
    {
      type: "paragraph",
      text: "Draw the calculated volume of diluent into the syringe. Confirm the volume visually against the syringe graduations before proceeding.",
    },
    {
      type: "subheading",
      text: "Step 5: Inject Diluent — With Care",
    },
    {
      type: "paragraph",
      text: "Critical: direct the diluent stream down the side of the vial — not directly onto the peptide powder. Forceful direct contact can mechanically damage peptide structure and promote aggregation. Allow the solution to run down the glass wall and contact the lyophilized cake gradually.",
    },
    {
      type: "subheading",
      text: "Step 6: Swirl, Do Not Shake",
    },
    {
      type: "paragraph",
      text: "Gently swirl the vial with a slow circular motion until the lyophilized material is fully dissolved. Do not shake — mechanical agitation can cause foaming and peptide aggregation. If the peptide does not fully dissolve after 1–2 minutes of gentle swirling, place the vial in the refrigerator for 10–15 minutes and attempt again.",
    },
    {
      type: "subheading",
      text: "Step 7: Verify and Label",
    },
    {
      type: "paragraph",
      text: "Once fully dissolved, the solution should be clear. Any visible cloudiness may indicate incomplete dissolution or aggregation. Label the vial immediately with compound name, concentration, date reconstituted, and initials. Transfer to 4°C storage.",
    },
    {
      type: "heading",
      text: "Common Reconstitution Errors",
    },
    {
      type: "table",
      headers: ["Error", "Consequence", "Correction"],
      rows: [
        ["Injecting diluent directly onto the peptide powder", "Aggregation, reduced potency", "Direct diluent down the vial wall"],
        ["Shaking rather than swirling", "Foaming, aggregation", "Use slow circular swirl motion only"],
        ["Using wrong diluent for hydrophobic peptides", "Incomplete dissolution", "Use acetic acid first, then dilute"],
        ["Incorrect volume calculation", "Wrong concentration, dosing errors", "Verify math before adding liquid"],
        ["No aseptic technique", "Bacterial contamination", "Use alcohol swabs and clean environment"],
        ["Storing reconstituted peptide at room temperature", "Rapid degradation", "Transfer to 4°C within minutes"],
      ],
    },
    {
      type: "heading",
      text: "Post-Reconstitution Storage",
    },
    {
      type: "paragraph",
      text: "Reconstituted peptides stored at 4°C are typically stable for 4–6 weeks depending on the compound. For longer storage, aliquot into single-use volumes and store at -20°C to minimize repeated freeze-thaw cycles. Most peptides tolerate 2–3 freeze-thaw cycles before significant activity loss; minimize these when possible.",
    },
    {
      type: "callout",
      text: "All Nexphoria peptides are supplied as lyophilized powder in sterile, septum-sealed vials optimized for standard bacteriostatic water reconstitution. COA documentation confirms purity and endotoxin status prior to reconstitution.",
    },
    {
      type: "disclaimer",
      text: "This protocol guide is for research purposes only. Peptides discussed are research compounds not approved for human therapeutic use. Researchers should follow all applicable institutional biosafety and regulatory guidelines.",
    },
  ],
};
